Page last updated: 2024-09-05

bilastine and Chronic Illness

bilastine has been researched along with Chronic Illness in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (80.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Biswas, D; Chowdhury, SN; Das, A; Ghosh, S; Podder, I; Sengupta, S1
Barkate, H; De, A; Deshmukh, G; Dhoot, D; Kochhar, AM; Sarda, A; Shah, B1
Biffi, A; Demonte, A; Fainello, M; Fernando, F; Guanti, MB; Liberati, S; Pepe, P1
Altrichter, S; Church, MK; Hawro, T; Labeaga, L; Magerl, M; Maurer, M; Metz, M; Weller, K; Zuberbier, T1
Kiss, I; Kuna, P; Novák, Z; Tortajada-Girbés, M; Valiente, R; Yáñez, A1
Furue, M; Hide, M; Saito, A; Togawa, M; Yagami, A2
Chicharro, P; de Argila, D; Rodríguez-Jiménez, P1
Antépara, I; Bogacka, E; Jáuregui, I; Medina, I; Oanta, A; Uhl, P; Valiente, R; Wesel, F; Zuberbier, T1
Bartra, J; Dávila, I; del Cuvillo, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A1

Reviews

1 review(s) available for bilastine and Chronic Illness

ArticleYear
Bilastine and quality of life.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21 Suppl 3

    Topics: Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; Piperidines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2011

Trials

6 trial(s) available for bilastine and Chronic Illness

ArticleYear
Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Double-Blind Method; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Quality of Life; Treatment Outcome; Urticaria

2020
Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:3

    Topics: Adult; Attention; Automobile Driving; Benzimidazoles; Chronic Disease; Computer Simulation; Dizziness; Female; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Piperidines; Prospective Studies; Rhinitis, Allergic; Urticaria; Young Adult

2018
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2016, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Benzimidazoles; Child; Child, Preschool; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Rhinitis, Allergic, Perennial; Treatment Outcome; Urticaria

2016
Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Allergology international : official journal of the Japanese Society of Allergology, 2017, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Aged; Benzimidazoles; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Phenotype; Piperidines; Quality of Life; Treatment Outcome; Urticaria; Young Adult

2017
One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    The Journal of dermatology, 2017, Volume: 44, Issue:4

    Topics: Adult; Benzimidazoles; Chronic Disease; Eczema; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Japan; Long Term Adverse Effects; Male; Middle Aged; Piperidines; Prurigo; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome; Urticaria

2017
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Allergy, 2010, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Piperidines; Quality of Life; Urticaria; Young Adult

2010

Other Studies

3 other study(ies) available for bilastine and Chronic Illness

ArticleYear
Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India.
    Dermatologic therapy, 2021, Volume: 34, Issue:1

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Humans; India; Piperidines; Urticaria

2021
Updosing of bilastine is effective in moderate to severe chronic spontaneous urticaria: A real-life study.
    Allergy, 2018, Volume: 73, Issue:10

    Topics: Benzimidazoles; Chronic Disease; Humans; Piperidines; Treatment Outcome; Urticaria

2018
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
    Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:4

    Topics: Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Middle Aged; Omalizumab; Piperidines; Prednisone; Urticaria; Viral Load; Viremia

2017